Patel Ronil A. 4
4 · Ocuphire Pharma, Inc. · Filed Apr 26, 2023
Insider Transaction Report
Form 4
Patel Ronil A.
Chief Business Officer
Transactions
- Award
Common Stock
2023-04-24+20,000→ 42,304 total - Award
Employee Stock Option (right to buy)
2023-04-24+30,000→ 30,000 totalExercise: $5.35Exp: 2033-04-23→ Common Stock (30,000 underlying)
Footnotes (2)
- [F1]Represents a grant of restricted stock units which vest in four equal installments on the first, second, third and fourth anniversary of the grant date of April 24, 2023.
- [F2]The option will vest with respect to 7,500 shares on April 24, 2024, with the balance vesting quarterly in twelve equal installments thereafter.